Please sign in to follow a disease.
Could a simple device replace the needle for blood tests?
NCT ID NCT06507566
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested a small device called Tasso+™ that collects blood from the upper arm, aiming to make blood draws easier for clinical trials and pandemic monitoring. About 200 healthy adults used the device, and researchers checked if the blood samples were good enough for lab tests. The goal was to see if this device could work outside of hospitals, so people could participate in studies from home.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Tasso+™ blood collection device
- What this could lead to
- If successful, this device could allow people to collect blood samples at home or in local clinics, making clinical trials and pandemic monitoring easier and more accessible.
- What could go wrong
- This was a small, early-phase study in healthy volunteers, so results may not apply to sicker patients. The device may still have issues with sample quality or user errors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
200 people
The number who actually took part.
- Started
-
Oct 2024
- Finished
-
Apr 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male or female adults (18 years of age or older, inclusive), at the time of informed consent. Participants who are deemed pregnant by urine pregnancy test at Screening remain eligible. * Able to understand and willing to provide informed consent and able to comply with the study procedures and restrictions. * Participant considered healthy or in well-compensated health according to medical history, concomitant medications, and physical examination (including vital signs). Exclusion Criteria: * Medical history, or physical examination (including vital signs) findings, that suggest to the Investigator that the participant has undiagnosed or untreated medical condition(s) that could confound the AE evaluation and thereby undermine the study objectives. * Any known medical history of infection with HIV (CD4\<200 and/or detectable viral load within the prior 3 months), hepatitis B (positive HBsAg), or hepatitis C (positive hepatitis C virus antibody). * Chronic illness for which a participant's immune system is suspected by the Investigator to be impaired or altered, such as cancer, autoimmune conditions, and diabetes. * Participation in another investigational study within 30 days of time of consent or plans to do so during the course of this study. * Large tattoos or skin eruptions overlying either of the deltoid muscles that could confound the monitoring for local reactogenicity following Tasso+™ administrations. * Use of systemic immunomodulatory therapy, including oral corticosteroids, within the past 6 months; or planned use of medications or nutritional supplements known to or which potentially could affect organ function within 30 days prior to screening until end of study. * Acute illness within 14 days prior to device use unless it is determined by the Investigator that the illness is mild in severity and unlikely to progress. * Of limited legal capacity. * Any condition (including suspected alcohol- or drug-related addiction) that precludes adequate understanding, cooperation, and/or compliance with study procedures or any condition that could pose a risk to the participant's safety per Investigator judgment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Victor Salib
Riverside, California, 92503, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A randomised, Triple-Blind, Placebo-Controlled, parallel study to investigate the effects of a chewable postbiotic tablet on oral health in healthy adults
- Can a new oral drug safely help older adults manage weight?
- Can a protein powder with creatine and fiber boost everyday Well-Being?
- Green tech or hidden stress? bus Drivers' hearts monitored behind the wheel
- Shout it out: can growls and screams raise pain tolerance?
- Scientists probe why brain stimulation works for some and not others